logo

For the Inventor, By the Inventor

Fukuoka, Japan

Norikazu Nishino

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Kyushu Institute of Technology, Riken Corporation, Japan Energy Corporation. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norikazu Nishino. Retrieved from https://idiyas.com/inventor/norikazu-nishino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 16.7

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:

goldMedal3 out of 156 
 
Kyushu Institute of Technology
 patents
silverMedal2 out of 892 
 
Riken Corporation
 patents
bronzeMedal1 out of 130 
 
Japan Energy Corporation
 patents
4. 1 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents
where one patent can have more than one assignee

Years Active: 2002-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 9012166 - Method for assaying histone methylation enzyme activity (2015-04-21),
2. 8158587 - Compound having histone deacetylase-inhibiting activity, and pharmaceutical composition comprising the compound as an active ingredient (2012-04-17),
3. 7662778 - Histone deacetylase inhibitor and process for producing the same (2010-02-16),
4. 7488712 - Histone deacetylase inhibitors and methods for producing the same (2009-02-10),
5. 6825317 - Cyclic tetrapeptide derivatives and pharmaceutical uses thereof (2004-11-30),
6. 6399568 - Cyclic tetrapeptide derivatives and medicinal use thereof (2002-06-04),

Title: Norikazu Nishino: Innovator in Histone Methylation Research

Introduction

Norikazu Nishino is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of histone methylation. With a total of 6 patents to his name, his work has advanced our understanding of enzyme activity related to histone modifications.

Latest Patents

Nishino's latest patents include a method for assaying histone methylation enzyme activity. This innovative method provides a way to measure histone methyltransferase activity and screen for compounds that inhibit this activity. Additionally, he has developed a reagent kit for measuring histone methyltransferase activity and a kit for screening inhibitors. His patents also encompass a novel compound with histone deacetylase-inhibiting activity, which is a cyclic tetrapeptide derivative. This compound is designed to be used in pharmaceutical compositions, showcasing his commitment to translating research into practical applications.

Career Highlights

Throughout his career, Norikazu Nishino has worked with esteemed institutions such as the Kyushu Institute of Technology and RIKEN Corporation. His research has not only contributed to academic knowledge but has also paved the way for potential therapeutic advancements in the field of epigenetics.

Collaborations

Nishino has collaborated with notable colleagues, including Minoru Yoshida and Sueharu Horinouchi. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Norikazu Nishino's work in histone methylation research exemplifies the intersection of innovation and practical application in biochemistry. His contributions continue to influence the field and hold promise for future developments in therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…